SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-24-103658
Filing Date
2024-09-27
Accepted
2024-09-27 15:20:19
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 tm2425095d1_424b5.htm 424B5 251934
2 GRAPHIC tm2423565d1_s1img001.jpg GRAPHIC 9731
3 GRAPHIC tm242356_5d2s1aimg003.jpg GRAPHIC 60231
  Complete submission text file 0001104659-24-103658.txt   349961
Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850
Business Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850 (734) 332-7800
Theriva Biologics, Inc. (Filer) CIK: 0000894158 (see all company filings)

IRS No.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-282024 | Film No.: 241334282
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)